Clinical Trial Update: VEGF Gene Transfer for Diabetic Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/Phase 2 clinical trial evaluating vascular endothelial growth factor gene transfer for diabetic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• VEGF gene transfer

Snippet

Sponsor: Losordo, Douglas, M.D. | Conditions: Diabetic Neuropathy | Phase 1, Phase 2 | Status: COMPLETED